DRGT 63Alternative Names: DRGT-63
Latest Information Update: 26 Jul 2016
At a glance
- Originator Druggability Technologies
- Class Antifungals; Echinocandins
- Mechanism of Action Glucan synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Mycoses